SE8505569D0 - Enteralt preparat - Google Patents

Enteralt preparat

Info

Publication number
SE8505569D0
SE8505569D0 SE8505569A SE8505569A SE8505569D0 SE 8505569 D0 SE8505569 D0 SE 8505569D0 SE 8505569 A SE8505569 A SE 8505569A SE 8505569 A SE8505569 A SE 8505569A SE 8505569 D0 SE8505569 D0 SE 8505569D0
Authority
SE
Sweden
Prior art keywords
preparation
enteric
hydrophobic substance
enteral preparation
enteral
Prior art date
Application number
SE8505569A
Other languages
English (en)
Swedish (sv)
Inventor
C Bogentoft
Original Assignee
Aco Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aco Laekemedel Ab filed Critical Aco Laekemedel Ab
Priority to SE8505569A priority Critical patent/SE8505569D0/xx
Publication of SE8505569D0 publication Critical patent/SE8505569D0/xx
Priority to PCT/SE1986/000538 priority patent/WO1987003198A1/fr
Priority to ES86907000T priority patent/ES2018479B3/es
Priority to EP86850402A priority patent/EP0225303A1/fr
Priority to DE8686907000T priority patent/DE3673998D1/de
Priority to AU67244/87A priority patent/AU595276B2/en
Priority to PH34519A priority patent/PH23944A/en
Priority to JP61506351A priority patent/JP2608402B2/ja
Priority to EP86907000A priority patent/EP0246294B1/fr
Priority to KR870700637A priority patent/KR880700664A/ko
Priority to DK386287A priority patent/DK386287A/da
Priority to GR90400664T priority patent/GR3000834T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8505569A 1985-11-25 1985-11-25 Enteralt preparat SE8505569D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE8505569A SE8505569D0 (sv) 1985-11-25 1985-11-25 Enteralt preparat
EP86907000A EP0246294B1 (fr) 1985-11-25 1986-11-24 Emploi d'une substance hydrophobe pour preparer une preparation enterique permettant de traiter l'obesite, et preparation enterique
DE8686907000T DE3673998D1 (de) 1985-11-25 1986-11-24 Verwendung einer hydrophoben substanz zur herstellung einer enterischen zubereitung zur behandlung der fettleibigkeit, sowie eine enterische zubereitung.
ES86907000T ES2018479B3 (es) 1985-11-25 1986-11-24 Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica.
EP86850402A EP0225303A1 (fr) 1985-11-25 1986-11-24 Utilisation d'une substance hydrophobique pour la préparation d'un médicament entérique pour le traitement de l'obésité et composition entérique
PCT/SE1986/000538 WO1987003198A1 (fr) 1985-11-25 1986-11-24 Emploi d'une substance hydrophobe pour preparer une preparation enterique permettant de traiter l'obesite, et preparation enterique
AU67244/87A AU595276B2 (en) 1985-11-25 1986-11-24 Use of a hydrophobic substance for preparing an enteric preparation for treatment of obesity and an enteric preparation
PH34519A PH23944A (en) 1985-11-25 1986-11-24 Enteric preparation
JP61506351A JP2608402B2 (ja) 1985-11-25 1986-11-24 腸内調合剤
KR870700637A KR880700664A (ko) 1985-11-25 1987-07-22 비만치료용 장용성제제
DK386287A DK386287A (da) 1985-11-25 1987-07-24 Anvendelse af et hydrofobt stof til fremstilling af et enterisk praeparat til behandling af fedme samt enteriske praeparater
GR90400664T GR3000834T3 (en) 1985-11-25 1990-09-18 Use of a hydrophobic substance for preparing an enteric preparation for treatment of obesity and an enteric preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505569A SE8505569D0 (sv) 1985-11-25 1985-11-25 Enteralt preparat

Publications (1)

Publication Number Publication Date
SE8505569D0 true SE8505569D0 (sv) 1985-11-25

Family

ID=20362239

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505569A SE8505569D0 (sv) 1985-11-25 1985-11-25 Enteralt preparat

Country Status (11)

Country Link
EP (2) EP0246294B1 (fr)
JP (1) JP2608402B2 (fr)
KR (1) KR880700664A (fr)
AU (1) AU595276B2 (fr)
DE (1) DE3673998D1 (fr)
DK (1) DK386287A (fr)
ES (1) ES2018479B3 (fr)
GR (1) GR3000834T3 (fr)
PH (1) PH23944A (fr)
SE (1) SE8505569D0 (fr)
WO (1) WO1987003198A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903232B2 (ja) * 1990-01-09 1999-06-07 株式会社アドバンス 脂質吸収阻害剤
FR2663222A1 (fr) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule de liquide huileux.
US5322697A (en) 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
WO2001050874A2 (fr) * 2000-01-07 2001-07-19 Monsanto Technology Llc Composition de matiere grasse hypocalorique
US7025984B1 (en) 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
DE10044846A1 (de) * 2000-09-11 2002-04-04 Guenther Beisel Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung
MXPA03008823A (es) 2001-03-27 2004-08-12 Univ California Metodos, compuestos y composiciones para reducir la grasa corporal y modular el metabolismo de los acidos grasos.
WO2003082240A1 (fr) * 2002-03-30 2003-10-09 Beisel Guenther Preparation contenant un acide gras pour la diminution d'appetit, le rassasiement ou la reduction de poids
SE0203886D0 (sv) * 2002-12-27 2002-12-27 Ltp Lipid Technologies Provide Glycerolesterprodukt och dess användning
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
WO2007115899A1 (fr) * 2006-04-07 2007-10-18 Unilever N.V. Produits alimentaires augmentant la satiété
WO2009144268A1 (fr) * 2008-05-30 2009-12-03 Dsm Ip Assets B.V. Composition pour augmenter le temps de transit gastro-intestinal
US9757346B2 (en) 2008-09-03 2017-09-12 Volant Holdings Gmbh Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
WO2010102041A2 (fr) * 2009-03-04 2010-09-10 Meyer Nutriceuticals, Llc Composition et procédé de maîtrise du diabète
JP2012522737A (ja) * 2009-04-03 2012-09-27 ディーエスエム アイピー アセッツ ビー．ブイ． 満腹誘発組成物
US9237762B2 (en) 2010-05-24 2016-01-19 Swedish Oat Fiber Ab Aqueous dispersion comprising galactolipids and method for production thereof
CN106794143A (zh) * 2014-08-11 2017-05-31 佩罗拉股份有限公司 诱导饱腹感的方法
US11504330B2 (en) 2014-08-11 2022-11-22 Perora Gmbh Formulation comprising particles containing a water-swellable or water-soluble polymeric component and a lipid component
EP3319592A1 (fr) 2015-07-07 2018-05-16 perora GmbH Méthode d'induction de la satiété

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4174M (fr) * 1965-02-15 1966-05-23
DE2344958A1 (de) * 1973-09-06 1975-03-20 Hans Dr Zahn Appetitzuegler
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
JPS59175425A (ja) * 1983-03-25 1984-10-04 Otsuka Pharmaceut Co Ltd 脳卒中予防剤
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid

Also Published As

Publication number Publication date
EP0246294B1 (fr) 1990-09-05
AU595276B2 (en) 1990-03-29
GR3000834T3 (en) 1991-11-15
EP0246294A1 (fr) 1987-11-25
EP0225303A1 (fr) 1987-06-10
PH23944A (en) 1990-01-23
WO1987003198A1 (fr) 1987-06-04
ES2018479B3 (es) 1991-04-16
DK386287D0 (da) 1987-07-24
KR880700664A (ko) 1988-04-11
AU6724487A (en) 1987-07-01
DE3673998D1 (de) 1990-10-11
JPS63501425A (ja) 1988-06-02
DK386287A (da) 1987-07-24
JP2608402B2 (ja) 1997-05-07

Similar Documents

Publication Publication Date Title
SE8505569D0 (sv) Enteralt preparat
SE8504720L (sv) Ny lekemedelsberedning
IL88083A0 (en) Controlled release pharmaceutical dosage form and its preparation
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
ATE119766T1 (de) Zubereitung für den magen.
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
NO177376C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO168361C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye adenosinderivater
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DE3764111D1 (de) Arzneimittelkombination.
NO178134C (no) Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse
NO167386C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfider med anvendelse som immunmodulatorer.
MY101916A (en) Etoposide oral dosage form.
KR880002521A (ko) 약제 제형
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물